基亞生物科技股份有限公司/Medigen Biotechnology Corp.
基亞生物科技股份有限公司/Medigen Biotechnology Corp.
  • About
    • Company Overview
    • Our Vision
    • Corporate Structure
    • Corporate Governance
      • Board of Directors
      • Remuneration Committee
      • Organization and Operation of Internal Audit
      • Corporate Governance Status
      • Corporate Regulations
      • Corporate Social Responsibility Status
    • Management
    • Careers
    • Subsidiaries
      • Medigen Vaccine Biologics Corporation
      • TBG Diagnostics Limited
      • Winston Medical & Biotech Group
  • Cell Therapy
    • MAGICELLl–NK (Natural killer cells)
    • MAGICELL®-GDT​(T cells)
    • GTP certificated cell processing facility
    • Cell Therapy Cooperation Agency
    • Cell Therapy Regulation in Taiwan
  • COVID-19
  • CLINICAL TRIALS
    • Product Pipelines
    • NK CELL (MAGICELL-NK)
    • OBP-301 (Telomelysin)​
  • NEWS
    • Material Information
      • 2025
      • 2024
      • 2023
      • 2021
    • Financial Statement
    • Shareholder Services
  • Investors
    • Financial Statements
      • Monthly Revenue Statement
      • Quarterly and Annual Report
    • Shareholder Services
      • Share Price
      • Shareholder Meeting Document
    • Contact Information
    • Stakeholders
  • Language
    • 中文 (繁)
    • English
    • 中文 (简)

Blog

Home | NEWS | Medigen Vaccine Biologics Co. listed on Taiwan OTC stock market (emerging stock market) on Aug 6th, 2015.

Medigen Vaccine Biologics Co. listed on Taiwan OTC stock market (emerging stock market) on Aug 6th, 2015.

0
By Teddy
2015-09-16
NEWS


2015/8/3: Press conference to announce Medigen Vaccine Biologics Co.(MVC) listing on Taiwan OTC stock market (emerging stock market).

2015/8/6: MVC listed on Taiwan OTC stock market (emerging stock market). (Listing No. 6547)

Related news (in Chinese):
1. Liberty Times Net
2. money.udn.com
3. cnYES.com

  • News
  • Financial Statement
  • Shareholder Services
previous postnext post
14F., No.3, Park St., Nangang Dist., Taipei City 11503, Taiwan (R.O.C)‧Copyright© 2021-2025 Medigen Biotechnology Corp. All rights reserved.